Global Minimally Invasive Biopsy Techniques Market Assessment, By Product Offered [Tests, Kits & Consumables, Instruments], By Technique [Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others], By Circulating Biomarker [Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others], By Application [Clinical, Therapeutic], By End-user [Hospitals & Clinics, Academic & Research Institutions, Ambulatory Care Centres], By Region, Opportunities and Forecast, 2016-2030F
Global Minimally Invasive Biopsy Techniques Market size was valued at USD 3.89 billion in 2022 which is expected to reach USD 6.93 billion in 2030 with a CAGR of 7.49% for the forecast period between 2023 and 2030.
Home>Industry Reports>Global Minimally Invasive Biopsy Techniques Market Assessment, Opportunities and Forecast, 2016-2030F
Global Minimally Invasive Biopsy Techniques Market size was valued at USD 3.89 billion in 2022 which is expected to reach USD 6.93 billion in 2030 with a CAGR of 7.49% for the forecast period between 2023 and 2030. Significant growth in the market is driven by several factors such as the increasing prevalence of cancer worldwide and is marked by notable advancements. The development of imaging-guided biopsy techniques, such as ultrasound-guided and MRI-guided biopsies, has enhanced the precision and accuracy of tissue sampling. These techniques allow for real-time visualization of the biopsy site, enabling physicians to target specific lesions and obtain high-quality samples. Additionally, the integration of robotics and artificial intelligence (AI) has further refined the biopsy process, enhanced procedural efficiency, and reduced human error. Furthermore, there have been notable developments in the field of liquid biopsy, which involves the analysis of circulating tumor cells, cell-free DNA, or other biomarkers in the blood.
For example, Roche launched the FoundationOne®Liquid CDx test, a comprehensive liquid biopsy assay. It employs next-generation sequencing to detect multiple genetic alterations in ctDNA extracted from blood samples. The test is designed to identify genomic alterations in solid tumors, aiding in the selection of targeted therapies and monitoring treatment response.
Minimally invasive biopsy techniques refer to procedures that enable the extraction of tissue samples for diagnostic purposes with minimal damage to surrounding tissues and reduced patient discomfort. Minimally invasive biopsy techniques offer a less invasive alternative to traditional open suragical biopsies, making them more appealing to patients and physicians.
Increase Demand for Early and Accurate Diagnosis
Early and accurate diagnosis is crucial for successful treatment outcomes in various medical conditions, including cancer. Minimally invasive biopsy techniques offer a less invasive and safer alternative to traditional biopsy techniques, making it a preferred choice for patients and healthcare providers. By detecting the presence of cancer cells at an early stage, the minimally invasive biopsy technique can help initiate timely and appropriate treatment, which can significantly improve patient outcomes. Therefore, increasing awareness among patients and healthcare providers about the benefits of early and accurate diagnosis through minimally invasive biopsy techniques can lead to a rise in demand for these techniques in the Global Minimally Invasive Biopsy Technique Market. Additionally, research and development to improve the accuracy and effectiveness of these techniques can further drive demand and market growth.
Technological Advancements
The Global Minimally Invasive Biopsy Techniques Market has seen significant technological advancements in recent years. One of the most notable developments has been the introduction of robotic-assisted biopsy systems that enable more accurate and less invasive procedures. Additionally, the development of advanced imaging technologies, such as ultrasound and magnetic resonance imaging (MRI), has improved the accuracy of biopsies and reduced the need for more invasive procedures. Other technological advancements, such as the use of disposable biopsy needles and the development of real-time image guidance systems, have also improved the safety and efficiency of minimally invasive biopsies. These technological advancements are expected to continue to drive growth in the market in the coming years.
Liquid Biopsy Segment Leads the Market
Tissue biopsies are the gold standard for diagnosing cancer and profiling tumours. Despite this, biopsy procedures have been linked to a number of limitations, prompting a demand for less intrusive and more precise alternatives. Liquid biopsies are a promising contender for determining the prognosis and diagnosis of cancer in patients. Because of the large number of analytes flowing in the bloodstream that may be employed for liquid biopsy testing, it is a promising tool for the clinical care of oncological patients. Several companies focus on the launch of new liquid biopsy products in line with the same.
For example, BillionToOne, a molecular diagnostics company, launched a range of Oncology liquid biopsy products Northstar Response and Northstar Select in July 2022. Northstar Response offers a tissue-independent therapy response monitoring test, whereas Northstar Select is a thorough pan-cancer somatic mutation screening panel. Both items are now accessible for usage in research at a few prestigious academic cancer centres.
Cell Free DNA (cfDNA) Segment Dominates
The cell-free DNA segment is set to dominate the global market for minimally invasive biopsy procedures. cfDNA is the fragmented DNA delivered into the circulation by cells dying naturally or as a result of illnesses such as cancer. Several reasons contribute to this segment's dominance. For a start, cfDNA analysis provides an alternative to standard tissue biopsies, removing the necessity for invasive surgeries and decreasing patient suffering. Secondly, cfDNA analysis allows for real-time monitoring of disease progression, treatment response, and detection of genetic abnormalities, making it a valuable tool for personalized medicine. Furthermore, advancements in technology, such as next-generation sequencing (NGS) and digital PCR, have improved the sensitivity and accuracy of cfDNA analysis, further driving its adoption and market dominance. The widespread applicability and benefits of cfDNA analysis position it as a leading segment in the global minimally invasive biopsy techniques market.
Government Initiatives
In order to increase political commitment to cancer prevention and control on a worldwide scale, WHO and IARC have worked together with other UN organizations. In addition to working with other UN organisations, such as the International Atomic Energy Agency, to track cancer prevalence (as part of the Global Initiative on Cancer Registries' activities), it aims to reach out to nations where data is scarce by conducting research on the causes of human cancer and the mechanisms of carcinogenesis.
Additionally, it focuses on identifying the "best buys" and other high-priority, cost-effective cancer prevention and control measures, such as minimally invasive biopsy techniques, and it also offers guidelines and standards to guide the creation and implementation of programmes for cancer prevention, early detection, screening, treatment, palliative care, and survivorship care in both adults and children. The effort also include raising awareness about the use of minimally invasive biopsy methods to improve access to cancer therapies by supporting regional and governmental health systems.
Impact of COVID-19
The market for minimally invasive biopsy techniques has been significantly impacted by the COVID-19 Pandemic which disrupted the global supply chain of medical devices and equipment, resulting in a decrease in the availability of minimally invasive biopsy devices. The delay or cancellation of elective procedures has led to a decrease in demand for minimally invasive biopsy procedures. Additionally, the shift towards telemedicine and virtual consultations has also impacted the market. However, the pandemic has also increased the demand for diagnostic testing, including minimally invasive biopsies, to diagnose and monitor COVID-19-related complications.
Impact of Russia-Ukraine War
The Russia-Ukraine war had a limited impact on the global minimally invasive biopsy techniques market. While Ukraine is a significant manufacturer of medical devices, including minimally invasive biopsy devices, the global market has not been heavily affected. The war has disrupted the supply chain of medical devices and equipment in Ukraine, leading to a decrease in the availability of these devices in the region. However, the impact on the global market has been minimal as other countries continue to manufacture and supply these devices. It is worth noting that the ongoing conflict has also led to a decrease in demand for medical procedures in Ukraine, including minimally invasive biopsies, due to the strain on the healthcare system and limited access to medical facilities in conflict-affected areas.
Report Scope
Global Minimally Invasive Biopsy Techniques Market Assessment, Opportunities and Forecast, 2016-2030F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative & quantitative assessment of the current state of the minimally invasive biopsy techniques globally, industry dynamics and challenges. The report includes market size, segmental shares, growth trends, COVID-19 and Russia-Ukraine war impact, opportunities and forecast between 2023 and 2030. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2022 |
|
Historical Period |
2016-2021 |
|
Forecast Period |
2023-2030 |
|
Projected Growth Rate |
CAGR of 7.49% between 2023 and 2030 |
|
Revenue forecast in 2030 |
USD 6.93 billion |
|
Units |
Revenue in USD billion |
|
Segments Covered |
Product Offered, Technique, Circulating Biomarker, Application, End-user |
|
Regions Covered |
North America, Europe, South America, Asia Pacific, Middle East, and Africa
|
|
Key Companies Profiled |
Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, QIAGEN NV, Guardant Health, Inc., Veracyte, Inc., Myriad Genetics, Inc., Biocept, Inc., NeoGenomics Laboratories, Inc., Adaptive Biotechnologies Corporation, DermTech, Inc. |
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfil your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, Global Minimally Invasive Biopsy Techniques have been segmented into following categories:
1. By Product Offered
1.1. Tests
1.2. Kits & Consumables
1.3. Instruments
2. By Technique
2.1. Liquid Biopsy
2.2. Optical Biopsy
2.3. Brush Biopsy
2.4. Pigmented Lesion Assays
2.5. Others
3. By Circulating Biomarker
3.1. Circulating Tumor Cells (CTCs)
3.2. Cell Free DNA (cfDNA)
3.3. Circulating Tumor DNA (ctDNA)
3.4. Extracellular Vesicles
3.5. Others
4. By Application
4.1. Clinical
4.1.1.Treatment Monitoring
4.1.2.Prognosis & Recurrence Monitoring
4.1.3.Treatment Selection
4.1.4.Others
4.2. Therapeutic
4.2.1.Lung Cancer
4.2.2.Breast Cancer
4.2.3.Prostate Cancer
4.2.4.Colorectal Cancer
4.2.5.Others
5. By End-user
5.1. Hospitals & Clinics
5.2. Academic & Research Institutions
5.3. Ambulatory Care Centers
6. By Region
6.1. North America
6.2. Europe
6.3. South America
6.4. Asia-Pacific
6.5. Middle East & Africa
Key Player Landscape and Outlook
Multiple prominent manufacturers are fighting for market share in the highly competitive market for minimally invasive biopsy procedures. The companies offer a wide range of minimally invasive biopsy devices and compete based on product quality, innovation, and pricing. In recent years, there has been a significant focus on product development and innovation, with companies investing in research and development to develop new and advanced minimally invasive biopsy devices. The market is also characterized by strategic collaborations, partnerships, and mergers and acquisitions, with companies seeking to expand their product portfolios and geographic reach.
For instance, Biocept is a prominent commercial supplier of testing services that allow doctors to discover and track cancer biomarkers in cerebrospinal fluid samples. Biocept's test menu, via CNSideTM, emphasises cancer biomarkers that are clinically actionable according to clinical treatment criteria established by the NCCN® (National Comprehensive Cancer Network®).
Key Players Operating in Global Minimally Invasive Biopsy Techniques
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche AG
- QIAGEN NV
- Guardant Health, Inc.
- Veracyte, Inc.
- Myriad Genetics, Inc.
- Biocept, Inc.
- NeoGenomics Laboratories, Inc.
- Adaptive Biotechnologies Corporation
- DermTech, Inc.
If you can't find what you're searching for or have any custom requirements for Global Minimally Invasive Biopsy Techniques Market, you may approach our team at info@marketsandata.com
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Impact of COVID-19
4. Impact of Russia-Ukraine War
5. Executive Summary
6. Global Minimally Invasive Biopsy Techniques Market Outlook, 2016-2030F
6.1. Market Size & Forecast
6.1.1.By Value
6.2.1. Tests
6.2.2.Kits & Consumables
6.2.3.Instruments
6.3. By Technique
6.3.1.Liquid Biopsy
6.3.2.Optical Biopsy
6.3.3.Brush Biopsy
6.3.4.Pigmented Lesion Assays
6.3.5.Others
6.4. By Circulating Biomarker
6.4.1.Circulating Tumor Cells (CTCs)
6.4.2.Cell Free DNA (cfDNA)
6.4.3.Circulating Tumor DNA (ctDNA)
6.4.4.Extracellular Vesicles
6.4.5.Others
6.5. By Application
6.5.1. Clinical
6.5.1.1. Treatment Monitoring
6.5.1.2. Prognosis & Recurrence Monitoring
6.5.1.3. Treatment Selection
6.5.1.4. Others
6.5.2.Therapeutic
6.5.2.1. Lung Cancer
6.5.2.2. Breast Cancer
6.5.2.3. Prostate Cancer
6.5.2.4. Colorectal Cancer
6.5.2.5. Others
6.6. By End-user
6.6.1.Hospitals & Clinics
6.6.2.Academic & Research Institutions
6.6.3.Ambulatory Care Centers
6.7. By Region
6.7.1.North America
6.7.2.Europe
6.7.3.South America
6.7.4.Asia-Pacific
6.7.5.Middle East & Africa
6.8. By Company Market Share (%), 2022
7. Global Minimally Invasive Biopsy Techniques Market Outlook, By Region, 2016-2030F
7.1. North America*
7.1.1. By Product Offered
7.1.1.1. Tests
7.1.1.2. Kits & Consumables
7.1.1.3. Instruments
7.1.2. By Technique
7.1.2.1. Liquid Biopsy
7.1.2.2. Optical Biopsy
7.1.2.3. Brush Biopsy
7.1.2.4. Pigmented Lesion Assays
7.1.2.5. Others
7.1.3.By Circulating Biomarker
7.1.3.1. Circulating Tumor Cells (CTCs)
7.1.3.2. Cell Free DNA (cfDNA)
7.1.3.3. Circulating Tumor DNA (ctDNA)
7.1.3.4. Extracellular Vesicles
7.1.3.5. Others
7.1.4. By Application
7.1.4.1. Clinical
7.1.4.1.1. Treatment Monitoring
7.1.4.1.2. Prognosis & Recurrence Monitoring
7.1.4.1.3. Treatment Selection
7.1.4.1.4. Others
7.1.4.2. Therapeutic
7.1.4.2.1. Lung Cancer
7.1.4.2.2. Breast Cancer
7.1.4.2.3. Prostate Cancer
7.1.4.2.4. Colorectal Cancer
7.1.4.2.5. Others
7.1.5. By End-user
7.1.5.1. Hospitals & Clinics
7.1.5.2. Academic & Research Institutions
7.1.5.3. Ambulatory Care Centers
7.1.6.1. By Product Offered
7.1.6.1.1. Tests
7.1.6.1.2. Kits & Consumables
7.1.6.1.3. Instruments
7.1.6.2. By Technique
7.1.6.2.1. Liquid Biopsy
7.1.6.2.2. Optical Biopsy
7.1.6.2.3. Brush Biopsy
7.1.6.2.4. Pigmented Lesion Assays
7.1.6.2.5. Others
7.1.6.3. By Circulating Biomarker
7.1.6.3.1. Circulating Tumor Cells (CTCs)
7.1.6.3.2. Cell Free DNA (cfDNA)
7.1.6.3.3. Circulating Tumor DNA (ctDNA)
7.1.6.3.4. Extracellular Vesicles
7.1.6.3.5. Others
7.1.6.4. By Application
7.1.6.4.1. Clinical
7.1.6.4.1.1. Treatment Monitoring
7.1.6.4.1.2. Prognosis & Recurrence Monitoring
7.1.6.4.1.3. Treatment Selection
7.1.6.4.1.4. Others
7.1.6.4.2. Therapeutic
7.1.6.4.2.1. Lung Cancer
7.1.6.4.2.2. Breast Cancer
7.1.6.4.2.3. Prostate Cancer
7.1.6.4.2.4. Colorectal Cancer
7.1.6.4.2.5. Others
7.1.6.5. By End-user
7.1.6.5.1. Hospitals & Clinics
7.1.6.5.2. Academic & Research Institutions
7.1.6.5.3. Ambulatory Care Centers
7.1.8.Mexico
*All segments will be provided for all regions and countries covered
7.2.1.Germany
7.2.2.France
7.2.3.Italy
7.2.4.United Kingdom
7.2.5.Russia
7.2.6.Netherlands
7.2.7.Spain
7.2.8.Turkey
7.2.9.Poland
7.3. South America
7.3.1.Brazil
7.3.2.Argentina
7.4. Asia-Pacific
7.4.1.India
7.4.2.China
7.4.3.Japan
7.4.4.Australia
7.4.5.Vietnam
7.4.6.South Korea
7.4.7.Indonesia
7.4.8.Philippines
7.5. Middle East & Africa
7.5.1.Saudi Arabia
7.5.2.UAE
7.5.3.South Africa
8. Market Mapping, 2022
8.1. By Product Offered
8.2. By Technique
8.3. By Circulating Biomarker
8.4. By Application
8.5. By End-user
8.6. By Region
9. Macro Environment and Industry Structure
9.1. Supply Demand Analysis
9.2. Import Export Analysis
9.3. Supply/Value Chain Analysis
9.4. PESTEL Analysis
9.4.1.Political Factors
9.4.2.Economic System
9.4.3.Social Implications
9.4.4.Technological Advancements
9.4.5.Environmental Impacts
9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
9.5. Porter’s Five Forces Analysis
9.5.1.Supplier Power
9.5.2.Buyer Power
9.5.3.Substitution Threat
9.5.4.Threat from New Entrant
9.5.5.Competitive Rivalry
10. Market Dynamics
10.1. Growth Drivers
10.2. Growth Inhibitors (Challenges, Restraints)
11. Key Players Landscape
11.1. Competition Matrix of Top Five Market Leaders
11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
11.4. SWOT Analysis (For Five Market Players)
11.5. Patent Analysis (If Applicable)
12. Pricing Analysis
13. Case Studies
14. Key Players Outlook
14.1. Thermo Fisher Scientific, Inc.
14.1.1. Company Details
14.1.2. Key Management Personnel
14.1.3. Products & Services
14.1.4. Key Market Focus & Geographical Presence
14.1.5. Financials (As Reported)
14.1.6. Recent Developments
14.2. F. Hoffmann-La Roche AG
14.3. QIAGEN NV
14.4. Guardant Health, Inc.
14.5. Veracyte, Inc.
14.6. Myriad Genetics, Inc.
14.7. Biocept, Inc.
14.8. NeoGenomics Laboratories, Inc.
14.9. Adaptive Biotechnologies Corporation
14.10. DermTech, Inc.
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
15. Strategic Recommendations
16. About Us & Disclaimer
List of Figures
Figure 1. Global Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 2. Global Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 3. Global Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 4. Global Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 5. Global Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 6. Global Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 7. Global Minimally Invasive Biopsy Techniques Market Share, By Region, In USD Billion, 2016-2030F
Figure 8. North America Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 9. North America Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 10. North America Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 11. North America Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 12. North America Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 13. North America Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 14. North America Minimally Invasive Biopsy Techniques Market Share, By Country, In USD Billion, 2016-2030F
Figure 15. United States Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 16. United States Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 17. United States Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 18. United States Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 19. United States Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 20. United States Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 21. Canada Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 22. Canada Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 23. Canada Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 24. Canada Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 25. Canada Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 26. Canada Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 27. Mexico Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 28. Mexico Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 29. Mexico Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 30. Mexico Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 31. Mexico Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 32. Mexico Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 33. Europe Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 34. Europe Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 35. Europe Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 36. Europe Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 37. Europe Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 38. Europe Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 39. Europe Minimally Invasive Biopsy Techniques Market Share, By Country, In USD Billion, 2016-2030F
Figure 40. Germany Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 41. Germany Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 42. Germany Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 43. Germany Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 44. Germany Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 45. Germany Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 46. France Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 47. France Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 48. France Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 49. France Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 50. France Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 51. France Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 52. Italy Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 53. Italy Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 54. Italy Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 55. Italy Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 56. Italy Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 57. Italy Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 58. United Kingdom Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 59. United Kingdom Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 60. United Kingdom Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 61. United Kingdom Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 62. United Kingdom Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 63. United Kingdom Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 64. Russia Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 65. Russia Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 66. Russia Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 67. Russia Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 68. Russia Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 69. Russia Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 70. Netherlands Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 71. Netherlands Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 72. Netherlands Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 73. Netherlands Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 74. Netherlands Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 75. Netherlands Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 76. Spain Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 77. Spain Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 78. Spain Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 79. Spain Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 80. Spain Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 81. Spain Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 82. Turkey Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 83. Turkey Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 84. Turkey Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 85. Turkey Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 86. Turkey Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 87. Turkey Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 88. Poland Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 89. Poland Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 90. Poland Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 91. Poland Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 92. Poland Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 93. Poland Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 94. South America Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 95. South America Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 96. South America Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 97. South America Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 98. South America Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 99. South America Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 100. South America Minimally Invasive Biopsy Techniques Market Share, By Country, In USD Billion, 2016-2030F
Figure 101. Brazil Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 102. Brazil Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 103. Brazil Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 104. Brazil Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 105. Brazil Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 106. Brazil Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 107. Argentina Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 108. Argentina Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 109. Argentina Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 110. Argentina Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 111. Argentina Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 112. Argentina Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 113. Asia-Pacific Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 114. Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 115. Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 116. Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 117. Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 118. Asia- Pacific Cream Market Share, By End-user, In USD Billion, 2016-2030F
Figure 119. Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Country, In USD Billion, 2016-2030F
Figure 120. India Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 121. India Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 122. India Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 123. India Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 124. India Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 125. India Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 126. China Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 127. China Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 128. China Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 129. China Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 130. China Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 131. China Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 132. Japan Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 133. Japan Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 134. Japan Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 135. Japan Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 136. Japan Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 137. Japan Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 138. Australia Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 139. Australia Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 140. Australia Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 141. Australia Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 142. Australia Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 143. Australia Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 144. Vietnam Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 145. Vietnam Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 146. Vietnam Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 147. Vietnam Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 148. Vietnam Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 149. Vietnam Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 150. South Korea Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 151. South Korea Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 152. South Korea Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 153. South Korea Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 154. South Korea Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 155. South Korea Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 156. Indonesia Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 157. Indonesia Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 158. Indonesia Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 159. Indonesia Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 160. Indonesia Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 161. Indonesia Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 162. Philippines Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 163. Philippines Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 164. Philippines Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 165. Philippines Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 166. Philippines Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 167. Philippines Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 168. Middle East & Africa Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 169. Middle East & Africa Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 170. Middle East & Africa Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 171. Middle East & Africa Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 172. Middle East & Africa Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 173. Middle East & Africa Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 174. Middle East & Africa Minimally Invasive Biopsy Techniques Market Share, By Country, In USD Billion, 2016-2030F
Figure 175. Saudi Arabia Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 176. Saudi Arabia Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 177. Saudi Arabia Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 178. Saudi Arabia Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 179. Saudi Arabia Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 180. Saudi Arabia Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 181. UAE Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 182. UAE Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 183. UAE Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 184. UAE Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 185. UAE Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 186. UAE Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 187. South Africa Minimally Invasive Biopsy Techniques Market, By Value, In USD Billion, 2016-2030F
Figure 188. South Africa Minimally Invasive Biopsy Techniques Market Share, By Product Offered, In USD Billion, 2016-2030F
Figure 189. South Africa Minimally Invasive Biopsy Techniques Market Share, By Technique, In USD Billion, 2016-2030F
Figure 190. South Africa Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, In USD Billion, 2016-2030F
Figure 191. South Africa Minimally Invasive Biopsy Techniques Market Share, By Application, In USD Billion, 2016-2030F
Figure 192. South Africa Minimally Invasive Biopsy Techniques Market Share, By End-user, In USD Billion, 2016-2030F
Figure 193. By Product Offered Map-Market Size (USD Billion) & Growth Rate (%), 2022
Figure 194. By Technique Map-Market Size (USD Billion) & Growth Rate (%), 2022
Figure 195. By Circulating Biomarker Map-Market Size (USD Billion) & Growth Rate (%), 2022
Figure 196. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2022
Figure 197. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2022
Figure 198. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2022
List of Table-Global Minimally Invasive Biopsy Techniques Market
Table 1. Pricing Analysis of Product Offerings from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
What is the market size and growth rate of the Global Minimally Invasive Biopsy Techniques Market?
What are the major drivers influencing the Growth of Global Minimally Invasive Biopsy Techniques Market?
What are the regions covered in the final report for Global Minimally Invasive Biopsy Techniques Market?
Who are the key players operating in Global Minimally Invasive Biopsy Techniques Market?
See Related Reports
Global Coffee Market Assessment, Opportunities and Forecast, 2017-2031F
Global coffee market is expected to experience growth due to consumers’ increasing preference for organic and premium coffee that offers freshness, superior quality of beans and roasts, and unique flavor profile. Additionally, the product innovation,....Read More
Published on
July 2024
4,500
Global Home Theater System Market Assessment, Opportunities and Forecast, 2017-2031F
Global home theater system market is expected to experience growth due to technological advancements, increasing disposable incomes, rising demand for high-definition content, integration with smart home systems, and the surge in streaming services p....Read More
Published on
July 2024
4,500
Global Baby Food Market Assessment, Opportunities and Forecast, 2017-2031F
Global baby food market is expected to experience growth due to factors such as consumers’ increasing awareness of the nutrients which are essential for babies development and introduction of wide variety of baby foods in the market from milk powders....Read More
Published on
July 2024
4,500
Global Isoflavones Market Assessment, Opportunities and Forecast, 2017-2031F
Global isoflavones market is expected to experience growth due to increasing consumer health awareness, rising demand for functional foods and nutraceuticals, advancements in extraction technologies, and expanding applications in cosmetics, pharmaceu....Read More
Published on
July 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
